Tag: CMC

How to Address Equipment Discrepancies During PPQ Planning to Avoid Tech Transfer Challenges Pharmaceutical professionals often encounter unexpected challenges during the Process Performance Qualification (PPQ) phase, primarily due to overlooked…

Effective Strategies for Managing Scale-Up Batch Failures in Pharmaceutical Manufacturing In the intricate world of pharmaceutical manufacturing, the transition from formulation and process development to commercial scale can sometimes lead…

Addressing Inconsistencies in Process Performance Ahead of Inspections: A Practical Playbook In pharmaceutical manufacturing, instances where process performance is not reproduced during the crucial phase of inspection preparation can pose…

Tackling Knowledge Transfer Gaps During Commercial Scale-Up with a Risk-Based Approach As pharmaceutical companies transition from small-scale development to commercial manufacturing, they often encounter knowledge transfer gaps that can jeopardize…

Addressing Incomplete Tech Transfer Packages During Inspection Prep The pharmaceutical landscape continuously evolves, presenting numerous challenges during the tech transfer phase, especially when preparing for regulatory inspections. An incomplete tech…

Addressing Knowledge Transfer Gaps During Commercial Scale-Up: A Governance Model Playbook Organizations often encounter knowledge transfer gaps during the scale-up phase of pharmaceutical manufacturing, jeopardizing product quality, compliance, and timelines.…

Addressing Incomplete Tech Transfer Packages during Commercial Scale-Up: A Practical Playbook In the realm of pharmaceutical manufacturing, the commercial scale-up phase is often fraught with challenges, especially when the tech…

Addressing Knowledge Transfer Gaps in PPQ Planning: A Risk-Based Approach for Scale-Up Strategy In pharmaceutical manufacturing, knowledge transfer between development and production is critical for ensuring successful scale-up. Knowledge transfer…

Addressing Knowledge Transfer Gaps in Inspection Preparation to Mitigate CAPA for Transfer Failures In the highly regulated pharmaceutical industry, the transition from one phase of the drug manufacturing process to…

Mitigating Scale-Up Batch Failures During Inspection Preparation As pharmaceutical professionals, encountering scale-up batch failures during crucial inspection preparations is a pressing issue that can jeopardize regulatory compliance and product quality.…

How to Address Equipment Differences During Commercial Scale-Up Efforts In the fast-evolving world of pharmaceutical manufacturing, inconsistencies during equipment transfer from laboratory to commercial scale can have significant repercussions. This…

Bridging Knowledge Transfer Gaps for Successful Inspection Preparation In the complex landscape of pharmaceutical manufacturing, ensuring that all stakeholders are aligned and informed is crucial for a successful inspection. Knowledge…